164 related articles for article (PubMed ID: 35728739)
1. Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coat.
Nkanga CI; Ortega-Rivera OA; Steinmetz NF
Nanomedicine; 2022 Aug; 44():102573. PubMed ID: 35728739
[TBL] [Abstract][Full Text] [Related]
2. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
[TBL] [Abstract][Full Text] [Related]
3. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
4. Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy.
Hu H; Yang Q; Baroni S; Yang H; Aime S; Steinmetz NF
Nanoscale; 2019 May; 11(19):9760-9768. PubMed ID: 31066418
[TBL] [Abstract][Full Text] [Related]
5. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
Murray AA; Wang C; Fiering S; Steinmetz NF
Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
[TBL] [Abstract][Full Text] [Related]
6. The
Nkanga CI; Chung YH; Shukla S; Zhou J; Jokerst JV; Steinmetz NF
Biomater Sci; 2021 Oct; 9(21):7134-7150. PubMed ID: 34591046
[TBL] [Abstract][Full Text] [Related]
7. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
[TBL] [Abstract][Full Text] [Related]
8. Iron oxide nanoparticles coated with polydopamine as a potential nano-photothermal agent for treatment of melanoma cancer: an in vivo study.
Beigi FH; Jazi SS; Shahbazi-Gahrouei D; Khaniabadi PM; Hafezi H; Monajemi R; Amiri GR
Lasers Med Sci; 2022 Dec; 37(9):3413-3421. PubMed ID: 35900685
[TBL] [Abstract][Full Text] [Related]
9. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
10. Polydopamine-Coated Manganese Carbonate Nanoparticles for Amplified Magnetic Resonance Imaging-Guided Photothermal Therapy.
Cheng Y; Zhang S; Kang N; Huang J; Lv X; Wen K; Ye S; Chen Z; Zhou X; Ren L
ACS Appl Mater Interfaces; 2017 Jun; 9(22):19296-19306. PubMed ID: 28508635
[TBL] [Abstract][Full Text] [Related]
11. Indocyanine green-loaded polydopamine-iron ions coordination nanoparticles for photoacoustic/magnetic resonance dual-modal imaging-guided cancer photothermal therapy.
Hu D; Liu C; Song L; Cui H; Gao G; Liu P; Sheng Z; Cai L
Nanoscale; 2016 Oct; 8(39):17150-17158. PubMed ID: 27539790
[TBL] [Abstract][Full Text] [Related]
12. Fe(III)-Chelated Polydopamine Nanoparticles for Synergistic Tumor Therapies of Enhanced Photothermal Ablation and Antitumor Immune Activation.
Xu N; Hu A; Pu X; Li J; Wang X; Wang J; Huang Z; Liao X; Yin G
ACS Appl Mater Interfaces; 2022 Apr; 14(14):15894-15910. PubMed ID: 35357136
[TBL] [Abstract][Full Text] [Related]
13. cRGD-Conjugated Fe
Fan X; Yuan Z; Shou C; Fan G; Wang H; Gao F; Rui Y; Xu K; Yin P
Int J Nanomedicine; 2019; 14():9631-9645. PubMed ID: 31824156
[TBL] [Abstract][Full Text] [Related]
14. Amplified Photoacoustic Signal and Enhanced Photothermal Conversion of Polydopamine-Coated Gold Nanobipyramids for Phototheranostics and Synergistic Chemotherapy.
Liu Y; Li Z; Yin Z; Zhang H; Gao Y; Huo G; Wu A; Zeng L
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14866-14875. PubMed ID: 32153178
[TBL] [Abstract][Full Text] [Related]
15. Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.
Zhang N; Song J; Liu Y; Liu M; Zhang L; Sheng D; Deng L; Yi H; Wu M; Zheng Y; Wang Z; Yang Z
J Control Release; 2019 Jul; 306():15-28. PubMed ID: 31132380
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
[TBL] [Abstract][Full Text] [Related]
17. TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy.
Jung E; Chung YH; Steinmetz NF
Bioconjug Chem; 2023 Sep; 34(9):1596-1605. PubMed ID: 37611278
[TBL] [Abstract][Full Text] [Related]
18. NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy.
Zhong W; Wong KH; Xu F; Zhao N; Chen M
Acta Biomater; 2022 Jun; 145():135-145. PubMed ID: 35381398
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment-Regulating Immunosenescence-Independent Nanostimulant Synergizing with Near-Infrared Light Irradiation for Antitumor Immunity.
Uthaman S; Pillarisetti S; Hwang HS; Mathew AP; Huh KM; Rhee JH; Park IK
ACS Appl Mater Interfaces; 2021 Feb; 13(4):4844-4852. PubMed ID: 33486952
[TBL] [Abstract][Full Text] [Related]
20. Polydopamine Nanoparticles as a Versatile Molecular Loading Platform to Enable Imaging-guided Cancer Combination Therapy.
Dong Z; Gong H; Gao M; Zhu W; Sun X; Feng L; Fu T; Li Y; Liu Z
Theranostics; 2016; 6(7):1031-42. PubMed ID: 27217836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
